NXGL (NEXGEL, Inc) Gross Profit Margin

NXGL (NEXGEL, Inc) - company brandmark

Stable demand for medical hydrogels ensures that NEXGEL, Inc. remains resilient to market shocks. Gross margins from sales confirm this reliability, while 33.40 determines the latest valuation metric. Revenues are based on the supply of patches to pharmacies and clinics. The growth strategy relies on organic expansion and the targeted acquisition of small niche brands to broaden the product portfolio.

NXGL - NEXGEL Inc Return on Gross Profit over the range 07/04/2022 - 11/20/2026

Analytical breakdowns and data insights for company NEXGEL (NXGL)

- price and consensus price forecast:
- business market valuation indicators:
Fundamental valuation:NXGL NEXGEL, Inc
Mass-produced product of nexgel.com

Gross margin determines the portion of revenue remaining after covering direct production costs, allowing for an assessment of cost management efficiency and the business's pricing power. An analysis of the final gross margin for NEXGEL, Inc. (NXGL) confirms the asset's high resilience, as patent protection for hydrogel compositions and FDA certification limit competition, providing the company with stable control over premium pricing.

Key competitors

Return on Gross Profit Intuitive|Gross Profitability Danaher Corp.|Gross Return on Sales BDX (Becton Dickinson & Co)|Return on Gross Profit STE (STERIS Corporation)|Gross Profit Ratio WST|Gross Profitability Baxter International Inc. BAX|Gross Profit Ratio MASI (Masimo Corp)|STVN - Gross Profitability|Teleflex Inc - Gross Profit Ratio|merit.com (MMSI) - Gross Profitability|Gross Profit Margin envistaco.com (NVST)|ICUI (ICU Medical Inc) - Gross Margin|Gross Profit Margin Dentsply Sirona Inc XRAY|Gross Profitability LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Gross Profit Rate|Gross Margin STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Gross Profit Margin|ZimVie Inc - Gross Margin|Gross Profit Margin AngioDynamics|CERS (Cerus Corp) - Return on Gross Profit|Alpha Teknova, Inc. - Gross Profit Rate|MGRM (Monogram Orthopedics Inc.) - Gross Margin|STSS: Gross Profit Rate|Return on Gross Profit INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Gross Return on Sales|Gross Margin KRMD (korumedical.com)|Return on Sales by Gross Profit Nyxoah, S.A. (NYXH)|MBOT - Gross Profitability|PDEX (Pro-Dex, Inc.) - Gross Return on Sales|ZTEK (Zentek Ltd) - Return on Gross Profit|ELUT - Return on Sales by Gross Profit|MLSS (Milestone Scientific Corporation) - Gross Margin|RVP (Retractable Technologies) - Gross Profit Ratio|Gross Margin HBIO|FEMY: Gross Profitability Margin|Gross Profitability MeihuaMed MHUA|POAI - Return on Gross Profit|Callan JMB - Gross Margin|Atrion Corp - Gross Profit Ratio|NURO (neurometrix.com) - Return on Gross Profit